These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30468907)

  • 21. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
    Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
    Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.
    Mazzu YZ; Liao YR; Nandakumar S; Jehane LE; Koche RP; Rajanala SH; Li R; Zhao H; Gerke TA; Chakraborty G; Lee GM; Nanjangud GJ; Gopalan A; Chen Y; Kantoff PW
    Oncogene; 2022 Jan; 41(5):671-682. PubMed ID: 34802033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
    He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
    Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
    Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
    Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of c-Jun activation domain-binding protein-1 in cancer: A systematic review and meta-analysis.
    Shi D; Mu S; Hu B; Zhang S; Liu J; Zhang Z; Shao Z
    J Cell Mol Med; 2021 Mar; 25(6):2750-2763. PubMed ID: 33550701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
    Wang Y; Sun Q; Mu N; Sun X; Wang Y; Fan S; Su L; Liu X
    Cell Commun Signal; 2020 Jul; 18(1):112. PubMed ID: 32665011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
    Huang M; Xiong H; Luo D; Xu B; Liu H
    Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSN5/JAB1 interacts with the centromeric components CENP-T and CENP-W and regulates their proteasome-mediated degradation.
    Chun Y; Lee M; Park B; Lee S
    J Biol Chem; 2013 Sep; 288(38):27208-27219. PubMed ID: 23926101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
    Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
    Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
    Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
    Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
    Lee EW; Oh W; Song HP; Kim WK
    BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation.
    Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ
    Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1.
    Echalier A; Pan Y; Birol M; Tavernier N; Pintard L; Hoh F; Ebel C; Galophe N; Claret FX; Dumas C
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1273-8. PubMed ID: 23288897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting.
    Liu Y; Shah SV; Xiang X; Wang J; Deng ZB; Liu C; Zhang L; Wu J; Edmonds T; Jambor C; Kappes JC; Zhang HG
    Am J Pathol; 2009 Apr; 174(4):1415-25. PubMed ID: 19246649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression pattern of the JAB1/CSN5 gene during murine embryogenesis: colocalization with NEDD8.
    Carrabino S; Carminati E; Talarico D; Pardi R; Bianchi E
    Gene Expr Patterns; 2004 Jul; 4(4):423-31. PubMed ID: 15183309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF.
    Wang L; Du WQ; Xie M; Liu MR; Huo FC; Yang J; Pei DS
    Gastric Cancer; 2020 Nov; 23(6):1003-1017. PubMed ID: 32458234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
    Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
    Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.